InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-41.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Lochner Daniel, 首席财务官. Director active across 3 companies, notably Oyster Point Pharma, Inc.. Aggregated, 12 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €350k. Activity tracked since 28 July 2021. The latest transaction was filed on 4 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lochner Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
26,500 股0Common StockSEC:0001791187-26-000005:0
6,000 股@ US$21.6127.9% 占其流量Common StockSEC:0001791187-26-000003:0
标准退出：2026年5月11日 (T+90)
2,077 股@ US$23.2210.4% 占其流量Common StockSEC:0001791187-26-000002:0
5,430 股0Common StockSEC:0001791187-25-000003:0
4,617 股@ US$54.14100.0% 占其流量Common StockSEC:0001415889-25-003350:0
标准退出：2025年5月6日 (T+90)
18,074 股0Common StockSEC:0001415889-25-003227:0
938 股@ US$11.701.9% 占其流量Common StockSEC:0001209191-23-001073:0
3,258 股@ US$11.206.9% 占其流量Common StockSEC:0001209191-22-059938:0
19,500 股0Common StockSEC:0001209191-22-002978:0
8,590 股@ US$11.5131.0% 占其流量Common StockSEC:0001209191-21-062476:0
7,500 股@ US$11.5126.3% 占其流量Common StockSEC:0001209191-21-054919:0
7,500 股@ US$11.5126.4% 占其流量Common StockSEC:0001209191-21-048517:0
12 条申报中的 12 条
About Lochner Daniel
Lochner Daniel is Chief Financial Officer. He has 12 filings in total, and across the 12 sampled filings the purchases total EUR 349902 with no sales, over the period from 2021-07-29 to 2026-03-05. The main filings concern Tectonic Therapeutic, Inc. and Oyster Point Pharma, Inc., with the modal transaction nature listed as Attribution.
